Jay R. Deshmukh

Jayadeep R. Deshmukh’s practice focuses on complex intellectual property and patent infringement cases that include major Hatch-Waxman Act and BPCIA (Biosimilars) litigations.  He regularly counsels international generic and biosimilars drug makers on product launches and defends clients against suits from brand-name manufacturers.  Jay also serves as settlement and Food and Drug Administration (FDA) counsel for smaller generic pharmaceutical companies, where he has a successful track record prevailing in exclusivity matters against the Office of the Chief Counsel of the FDA.

Jay also has extensive experience working with the Federal Trade Commission and advising companies who seek patent litigation counsel in the European Union (E.U.), where he defends clients in more than 10 E.U. jurisdictions.

Jay is recognized as a leading patent litigator by LMG Life Sciences.

Prior to joining Kasowitz, Jay served as Senior Vice President of Global IP at Ranbaxy Laboratories, an international generic pharmaceutical company, where he was responsible for the creation of the company’s global intellectual property department.  Including his Ranbaxy tenure, Jay has had significant experience handling Hatch-Waxman and Biosimilars matters for the last 25 years.